Searching for drugs that target multiple receptors for anthelmintics from African natural products

Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs

Volumn 9783642281754, Issue , 2012, Pages 127-150

  Geary, Timothy G ^a   Ubalijoro, Eliane ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTELLECTUAL PROPERTY; LAWS AND LEGISLATION; LEAD COMPOUNDS; RECOMBINANT PROTEINS; YEAST;

ANTIPARASITIC DRUGS; CAPE TOWN; CHEMICAL AND BIOLOGICALS; G PROTEIN COUPLED RECEPTORS; MECHANISM-BASED; MULTIPLE RECEPTORS; NATURAL PRODUCTS; PARASITE-; PARASITICS; UNIVERSITY OF BOTSWANA;

BIODIVERSITY;

EID: 84949179990     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-28175-4_6     Document Type: Chapter

References (48)

1. http://www.who.int/features/factfiles/neglected-tropical-diseases/ntd-facts/en/index.html. Accessed July 2011.
2. http://www.who.int/neglected-diseases/diseases/en/Accessed July 2011.
3. Hotez PJ, Brindley PJ, Bethony JM et al (2008) Helminth infections: The great neglected tropical diseases. J Clin Invest 118:1311-1321.
4. Crompton DWT Savioli L (2007) Helminthiasis for public health. CRC/Taylor and Francis Boca Raton FL 362pp.
5. Klopper RR (2006) Inventory of the African flora: A world first for the forgotten continent. S Afr J Sci 102:185-186.
6. Li JW-H, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325:161-165.
7. Molinari G (2009) Natural products in drug discovery: present status and perspective. In: Guzman CA, Feuerstein GZ (eds) Pharmaceutical biotechnology. Landes Bioscience and Springer Science+Business Media, Austin, TX, pp 13-27.
8. Hotez PJ, Molyneux DH, Fenwick A et al (2007) Control of neglected tropical diseases. N Engl J Med 357:1018-1027.
9. Geary TG, Woo K, McCarthy JS et al (2010) Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 40:1-13.
10. Geary TG, Gauvry N (2011) Anthelmintic discovery for human infections. In: Palmer MJ, Wells TNC (eds) Neglected diseases and drug discovery. Royal Society of Chemistry Press, Cambridge.
11. Geary TG, Mackcbrrenzie CD (2011) Progress and challenges in the discovery of macrofilaricidal drugs. Expert Rev Anti Infect Ther 9(8):681-695.
12. http://www.irinnews.org/report.aspx?reportid1/482486. Accessed Oct 2011.
13. Gamo F-J, Sanz LM, Vidal J et al (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465:305-310.
14. Rottmann M, McNamara C, Yeung BKS et al (2010) Spiroindolones, a potent compound class for the treatment of malaria. Science 329:1175-1180.
15. Geary TG, Thompson DP, Klein RD (1999) Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research. Int J Parasitol 29:105-112.
16. Geary TG (2011) Mechanism-based screening strategies for anthelmintic discovery. In: Caffrey C (ed) Parasitic helminths: Targets, drugs and vaccines. Wiley-VCH, Weinheim.
17. Klein RD, Geary TG (1997) Recombinant microorganisms as tools for high-throughput screening for non-antibiotic compounds. J Biomol Screen 2:41-49.
18. Geary TG (2001) Screening for parasiticides using recombinant microorganisms. In: Kirst HA, Yeh W-K, Zmijewski M, Bronson DB (eds) Enzyme technology for pharmaceutical and biotechnological applications. Dekker, New York, pp 323-341.
19. Woods D, Butler C, Williams T, Greenwood K (2010) Receptor-based discovery strategies for insecticides and parasiticides. In: Geary TG, Maule AG (eds) Neuropeptide systems as targetsfor parasite and pest control. Landes Bioscience and Springer Science+Business Media, Austin, TX, pp 1-9.
20. Geary TG, Woods DJ, Williams T, Nwaka S (2009) Target identification and mechanismbased screening for anthelmintics: Application of veterinary antiparasitic research programmes to search for new antiparasitic drugs for human indications. In: Selzer PM (ed) Drug discovery in infectious diseases. Wiley-VCH, Weinheim, pp 1-16.
21. Maule AG, Mousley A, Marks NJ et al (2002) Neuropeptide signaling systems - potential drug targets for parasite and pest control. Curr Top Med Chem 2:733-758.
22. McVeigh P, Geary TG, Maule AG (2006) On the FLP-side of nematode neuropeptides. Trends Parasitol 22:385-396.
23. Geary TG, Marks NJ, Maule AG et al (1999) Pharmacology of FMRFamide-related peptides (FaRPs) in helminths. Ann N Y Acad Sci 897:212-227.
24. Lowery DE, Geary TG, Kubiak TM, Larsen MJ (2007) G protein-coupled receptor-like receptors and modulators thereof. US Patent No. 7, 208, 591.
25. Greenwood K, Williams T, Geary T (2005) Nematode neuropeptide receptors and their development as anthelmintic screens. Parasitology 131:S169-S177.
26. Husson SJ, Mertens I, Janssen T et al (2007) Neuropeptidergic signaling in the nematode Caenorhabditis elegans. Prog Neurobiol 82:33-55.
27. Geary TG (2010) Non-peptide ligands for peptidergic G protein-coupled receptors. In: Geary TG, Maule AG (eds) Neuropeptide systems as targets for parasite and pest control. Landes Biosciences, Austin, TX, pp 10-26.
28. Woods DJ, Butler C, Williams T, Greenwood K (2010) Receptor-based discovery strategies for insecticides and parasiticides: A review. In: Geary TG, Maule AG (eds) Neuropeptide systems as targets for parasite and pest control. Landes Bioscience, Austin, TX, pp 1-9.
29. Wang ZX, Broach JR, Peiper SC (2006) Functional expression of CXCR4 in Saccharomyces cerevisiae in the development of powerful tools for the pharmacological characterization of CXCR4. Methods Mol Biol 332:115-127.
30. Minic J, Sautel M, Salesse R, Pajot-Augy E (2005) Yeast system as a screening tool for the pharmacological assessment of G protein coupled receptors. Curr Med Chem 12:961-969.
31. Brooks DR, Isaac RE (2002) Functional genomics of parasitic worms: The dawn of a new era. Parasitol Int 51:319-325.
32. Kubiak TM, Larsen MJ, Bowman JW et al (2008) FMRFamide-like peptides (FLPs) encoded by the flp18 precursor gene activate two isoforms of the orphan Caenorhabditis elegans Gprotein- coupled receptor Y58G8 heterologously expressed in mammalian cells. Biopolymers 90:339-348.
33. Birg€ul N, Weise C, Kreienkamp HJ, Richter D (1999) Reverse physiology in Drosophila: identification of a novel allatostatin-like neuropeptide and its cognate receptor structurally related to the mammalian somatostatin/galanin/opioid receptor family. EMBO J 18:5892-5900.
34. Lipinski CA, Lombardo F, Dominy BW et al (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26.
35. Tagboto S, Townson S (2001) Antiparasitic properties of medicinal plants and other naturally occurring products. Adv Parasitol 50:199-295.
36. Juliani HR, Simon J, Ho C-T (eds) (2010) African natural plant products. New discoveries and challenges in chemistry and quality. Oxford University Press, Kettering, 616 pp
37. http://www.napreca.net/Accessed July 2011.
38. Chibale K, Masimirembwa CM, Guantai EM (2011) Extracting molecular information from African natural products to facilitate unique African-led drug discovery efforts. Future Med Chem 3:257-261.
39. http://www.gibex.org/index.php?suj1/499. Accessed July 2011.
40. http://www.mcgill.ca/lifesciencescomplex/core/hts-hcs/chemical-libraries. Accessed July 2011.
41. Fura A, Shu Y-Z, Zhu M et al (2004) Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery. J Med Chem 47:4339-4351.
42. Hamilton C (2006) Biodiversity, biopiracy and benefits: what allegations of biopiracy tell us about intellectual property. Dev World Bioeth 6:158-173.
43. Frew SE, Liu VY, Singer PA (2009) A business plan to help the global South in its fight against neglected diseases. Health Aff (Millwood) 28:1760-1773.
44. Daar AS, Berndtson K, Persad DL, Singer PA (2007) How can developing countries harness biotechnology to improve health? BMC Public Health 7:346-355.
45. http://www.grandchallenges.ca/wp-content/uploads/integratedinnovation-EN.pdf Accessed July 2011.
46. Kingston DG (2011) Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod 74:496-511.
47. Nwaka S, Ilunga TB, Da Silva JS et al (2010) Developing ANDI: A novel approach to health product R&D in Africa. PLoS Med 7:e1000293.
48. Dushenkov V, Raskin I (2008) New strategy for the search of natural biologically active substances. Russ J Plant Physiol 55:564-567.